Home LiteratureArticle Details
PMID: 15362047 Published · ppublish English Journal Article Research Support, Non-U.S. Gov't Research Support, U.S. Gov't, P.H.S.

High resolution analysis of cellular immune responses in resolved and persistent hepatitis C virus infection.

Gastroenterology ·Vol. 127 ·No. 3 ·2004-09-00 ·Pages 924-36

Lauer GM, Barnes E, Lucas M, Timm J, Ouchi K, Kim AY, Day CL, Robbins GK, Casson DR, Reiser M, Dusheiko G, Allen TM, Chung RT, Walker BD, Klenerman P

Abstract

Cellular immune responses are thought to play a key role in the resolution of primary HCV infection. Although it has been consistently shown that CD4+ T-cell responses are maintained in those with spontaneous resolution but lost in those with persistent infection, the role of CD8+ T-cell responses remains controversial. Previous studies have largely focused on limited HLA alleles and predefined CD8+ T-cell epitopes, and, thus, comprehensive studies remain to be performed. To understand the composition of the immune response associated with spontaneous resolution, we comprehensively mapped CD8+ T-cell responses in 20 HLA-diverse persons with resolved HCV infection, using HCV peptides spanning the entire genome. We analyzed the magnitude, breadth, function, and phenotype using ELISpot, class-I tetramers, intracellular cytokine staining, and cytolytic assays. We studied in parallel HCV-specific responses and viral sequence variation in persistent infection. Responses in individuals with resolved infection were strong and broad with robust proliferation in response to antigen. Responses in those persistently infected were rarely detected ex vivo and, when present, were narrowly directed and weak. However, they also proliferated in vitro. Dominant target epitopes differed among individuals in both cohorts, despite frequently shared HLA-alleles. These data indicate that persisting, strong CD8+ T-cell responses are observed in the majority of persons with resolved HCV infection and provide support for strategies to boost CD8+ T-cell responses for the prevention or treatment of HCV infection but also highlight the diversity of responses that may need to be elicited to provide protection.

MeSH Terms
CD8-Positive T-Lymphocytes/immunology Epitopes, T-Lymphocyte/immunology HLA Antigens/immunology Hepacivirus/immunology Hepatitis C/immunology Humans Immunity, Cellular/immunology Remission, Spontaneous
Chemicals
Epitopes, T-Lymphocyte HLA Antigens
Authors & Affiliations
15 authors, click to expand affiliations / ORCID
Lauer Georg M
Partners AIDS Research Center, Massachusetts General Hospital and Harvard Medical School, Boston, Massachusetts, USA.
Barnes Eleanor
Lucas Michaela
Timm Joerg
Ouchi Kei
Kim Arthur Y
Day Cheryl L
Robbins Gregory K
Casson Deborah R
Reiser Markus
Dusheiko Geoffrey
Allen Todd M
Chung Raymond T
Walker Bruce D
Klenerman Paul
Article Info
Journal
Gastroenterology
Abbr.
Gastroenterology
ISSN
0016-5085
Published
2004-09-00
Pages
924-36
Language
English
Region
United States
NLM ID
0374630
Subset
IM
Grants
NIAID NIH HHS · R01 AI031563 · United States
NIAID NIH HHS · AI31563 · United States
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: product@genelibs.com